APO Research, Inc.

APO RESEARCH · REPORT

Artificial Intelligence Diagnostics

Selected research

Market Analysis & Forecast

Global Artificial Intelligence Diagnostics Market Analysis and Forecast 2026-2032

Market perspective

The global Artificial Intelligence Diagnostics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Intelligence Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence Diagnostics include Butterfly Network, Merative, Tempus, RetinAi, Nanox, Lunit, DiA Imaging, Subtle Medical and BrainMiner, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

Artificial Intelligence Diagnostics Segment by Company

Butterfly Network

Merative

Tempus

RetinAi

Nanox

Lunit

DiA Imaging

Subtle Medical

BrainMiner

GE

Siemens

Aidoc

Imagen Technologies, Inc.

VUNO, Inc.

Digital Diagnostics

NeuraSignal

Riverain Technologies, LLC

Philips

Microsoft

Viz.ai

RapidAI

Canon Medical

Enlitic

BioMind

ANNALISE-AI PTY LTD

icometrix

KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)

Artificial Intelligence Diagnostics Segment by Type

Services

Software

Hardware

Artificial Intelligence Diagnostics Segment by Application

Radiology

Oncology

Neurology

Cardiology

Chest & Lungs

Others

Artificial Intelligence Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artificial Intelligence Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artificial Intelligence Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Services Major Player Table 3. Software Major Player Table 4. Hardware Major Player Table 5. Global Artificial Intelligence Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Radiology Major Player Table 7. Oncology Major Player Table 8. Neurology Major Player Table 9. Cardiology Major Player Table 10. Chest & Lungs Major Player Table 11. Others Major Player Table 12. Artificial Intelligence Diagnostics Industry Trends Table 13. Artificial Intelligence Diagnostics Industry Drivers Table 14. Artificial Intelligence Diagnostics Industry Opportunities and Challenges Table 15. Artificial Intelligence Diagnostics Industry Restraints Table 16. Global Artificial Intelligence Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Artificial Intelligence Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Artificial Intelligence Diagnostics Market Share by Region (2021-2026) Table 19. Global Artificial Intelligence Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Artificial Intelligence Diagnostics Market Share by Region (2027-2032) Table 21. Global Artificial Intelligence Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Artificial Intelligence Diagnostics Revenue Market Share by Players (2021-2026) Table 23. Global Artificial Intelligence Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Artificial Intelligence Diagnostics Key Players Headquarters & Area Served Table 25. Global Artificial Intelligence Diagnostics Players, Product Type & Application Table 26. Global Artificial Intelligence Diagnostics Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Artificial Intelligence Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Artificial Intelligence Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Artificial Intelligence Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Artificial Intelligence Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Artificial Intelligence Diagnostics Revenue Market Share by Type (2021-2026) Table 33. Global Artificial Intelligence Diagnostics Revenue Market Share by Type (2027-2032) Table 34. Global Artificial Intelligence Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Artificial Intelligence Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Artificial Intelligence Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Artificial Intelligence Diagnostics Revenue Market Share by Application (2021-2026) Table 38. Global Artificial Intelligence Diagnostics Revenue Market Share by Application (2027-2032) Table 39. Butterfly Network Company Information Table 40. Butterfly Network Business Overview Table 41. Butterfly Network Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Butterfly Network Artificial Intelligence Diagnostics Product Portfolio Table 43. Butterfly Network Recent Development Table 44. Merative Company Information Table 45. Merative Business Overview Table 46. Merative Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Merative Artificial Intelligence Diagnostics Product Portfolio Table 48. Merative Recent Development Table 49. Tempus Company Information Table 50. Tempus Business Overview Table 51. Tempus Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Tempus Artificial Intelligence Diagnostics Product Portfolio Table 53. Tempus Recent Development Table 54. RetinAi Company Information Table 55. RetinAi Business Overview Table 56. RetinAi Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. RetinAi Artificial Intelligence Diagnostics Product Portfolio Table 58. RetinAi Recent Development Table 59. Nanox Company Information Table 60. Nanox Business Overview Table 61. Nanox Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Nanox Artificial Intelligence Diagnostics Product Portfolio Table 63. Nanox Recent Development Table 64. Lunit Company Information Table 65. Lunit Business Overview Table 66. Lunit Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Lunit Artificial Intelligence Diagnostics Product Portfolio Table 68. Lunit Recent Development Table 69. DiA Imaging Company Information Table 70. DiA Imaging Business Overview Table 71. DiA Imaging Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. DiA Imaging Artificial Intelligence Diagnostics Product Portfolio Table 73. DiA Imaging Recent Development Table 74. Subtle Medical Company Information Table 75. Subtle Medical Business Overview Table 76. Subtle Medical Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Subtle Medical Artificial Intelligence Diagnostics Product Portfolio Table 78. Subtle Medical Recent Development Table 79. BrainMiner Company Information Table 80. BrainMiner Business Overview Table 81. BrainMiner Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. BrainMiner Artificial Intelligence Diagnostics Product Portfolio Table 83. BrainMiner Recent Development Table 84. GE Company Information Table 85. GE Business Overview Table 86. GE Artificial Intelligence Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. GE Artificial Intelligence Diagnostics Product Portfolio Table 88. GE Recent Development Table 89. Siemens Company Information Table 90. Siemens Business Overview Table 91. Siemens Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Siemens Artificial Intelligence Diagnostics Product Portfolio Table 93. Siemens Recent Development Table 94. Aidoc Company Information Table 95. Aidoc Business Overview Table 96. Aidoc Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Aidoc Artificial Intelligence Diagnostics Product Portfolio Table 98. Aidoc Recent Development Table 99. Imagen Technologies, Inc. Company Information Table 100. Imagen Technologies, Inc. Business Overview Table 101. Imagen Technologies, Inc. Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Imagen Technologies, Inc. Artificial Intelligence Diagnostics Product Portfolio Table 103. Imagen Technologies, Inc. Recent Development Table 104. VUNO, Inc. Company Information Table 105. VUNO, Inc. Business Overview Table 106. VUNO, Inc. Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. VUNO, Inc. Artificial Intelligence Diagnostics Product Portfolio Table 108. VUNO, Inc. Recent Development Table 109. Digital Diagnostics Company Information Table 110. Digital Diagnostics Business Overview Table 111. Digital Diagnostics Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Digital Diagnostics Artificial Intelligence Diagnostics Product Portfolio Table 113. Digital Diagnostics Recent Development Table 114. NeuraSignal Company Information Table 115. NeuraSignal Business Overview Table 116. NeuraSignal Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. NeuraSignal Artificial Intelligence Diagnostics Product Portfolio Table 118. NeuraSignal Recent Development Table 119. Riverain Technologies, LLC Company Information Table 120. Riverain Technologies, LLC Business Overview Table 121. Riverain Technologies, LLC Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Riverain Technologies, LLC Artificial Intelligence Diagnostics Product Portfolio Table 123. Riverain Technologies, LLC Recent Development Table 124. Philips Company Information Table 125. Philips Business Overview Table 126. Philips Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Philips Artificial Intelligence Diagnostics Product Portfolio Table 128. Philips Recent Development Table 129. Microsoft Company Information Table 130. Microsoft Business Overview Table 131. Microsoft Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Microsoft Artificial Intelligence Diagnostics Product Portfolio Table 133. Microsoft Recent Development Table 134. Viz.ai Company Information Table 135. Viz.ai Business Overview Table 136. Viz.ai Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Viz.ai Artificial Intelligence Diagnostics Product Portfolio Table 138. Viz.ai Recent Development Table 139. RapidAI Company Information Table 140. RapidAI Business Overview Table 141. RapidAI Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. RapidAI Artificial Intelligence Diagnostics Product Portfolio Table 143. RapidAI Recent Development Table 144. Canon Medical Company Information Table 145. Canon Medical Business Overview Table 146. Canon Medical Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Canon Medical Artificial Intelligence Diagnostics Product Portfolio Table 148. Canon Medical Recent Development Table 149. Enlitic Company Information Table 150. Enlitic Business Overview Table 151. Enlitic Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Enlitic Artificial Intelligence Diagnostics Product Portfolio Table 153. Enlitic Recent Development Table 154. BioMind Company Information Table 155. BioMind Business Overview Table 156. BioMind Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. BioMind Artificial Intelligence Diagnostics Product Portfolio Table 158. BioMind Recent Development Table 159. ANNALISE-AI PTY LTD Company Information Table 160. ANNALISE-AI PTY LTD Business Overview Table 161. ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Product Portfolio Table 163. ANNALISE-AI PTY LTD Recent Development Table 164. icometrix Company Information Table 165. icometrix Business Overview Table 166. icometrix Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. icometrix Artificial Intelligence Diagnostics Product Portfolio Table 168. icometrix Recent Development Table 169. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information Table 170. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview Table 171. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Product Portfolio Table 173. KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Development Table 174. North America Artificial Intelligence Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 175. North America Artificial Intelligence Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 176. North America Artificial Intelligence Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 177. North America Artificial Intelligence Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 178. North America Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. North America Artificial Intelligence Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 180. North America Artificial Intelligence Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 181. Europe Artificial Intelligence Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Artificial Intelligence Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Artificial Intelligence Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 184. Europe Artificial Intelligence Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 185. Europe Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Europe Artificial Intelligence Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 187. Europe Artificial Intelligence Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 188. China Artificial Intelligence Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 189. China Artificial Intelligence Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 190. China Artificial Intelligence Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 191. China Artificial Intelligence Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 192. Asia Artificial Intelligence Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia Artificial Intelligence Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia Artificial Intelligence Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 195. Asia Artificial Intelligence Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 196. Asia Artificial Intelligence Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 197. Asia Artificial Intelligence Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 198. Asia Artificial Intelligence Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 199. SAMEA Artificial Intelligence Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA Artificial Intelligence Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA Artificial Intelligence Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 202. SAMEA Artificial Intelligence Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 203. SAMEA Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Artificial Intelligence Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 205. SAMEA Artificial Intelligence Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 206. Research Programs/Design for This Report Table 207. Authors List of This Report Table 208. Secondary Sources Table 209. Primary Sources List of Figures Figure 1. Artificial Intelligence Diagnostics Image Figure 2. Global Artificial Intelligence Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Services Image Figure 5. Software Image Figure 6. Hardware Image Figure 7. Global Artificial Intelligence Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Artificial Intelligence Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Radiology Image Figure 10. Oncology Image Figure 11. Neurology Image Figure 12. Cardiology Image Figure 13. Chest & Lungs Image Figure 14. Others Image Figure 15. Global Artificial Intelligence Diagnostics Market Size (US$ Million) & (2021-2032) Figure 16. Global Artificial Intelligence Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Artificial Intelligence Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Artificial Intelligence Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Artificial Intelligence Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Artificial Intelligence Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Artificial Intelligence Diagnostics Revenue Market Share by Type (2021-2032) Figure 23. Global Artificial Intelligence Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Artificial Intelligence Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Artificial Intelligence Diagnostics Revenue Market Share by Application (2021-2032) Figure 26. North America Artificial Intelligence Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032) Figure 28. North America Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032) Figure 29. North America Artificial Intelligence Diagnostics Revenue Share by Country (2021-2032) Figure 30. United States Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Artificial Intelligence Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032) Figure 35. Europe Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032) Figure 36. Europe Artificial Intelligence Diagnostics Revenue Share by Country (2021-2032) Figure 37. Germany Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Artificial Intelligence Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032) Figure 47. China Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032) Figure 48. Asia Artificial Intelligence Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032) Figure 50. Asia Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032) Figure 51. Asia Artificial Intelligence Diagnostics Revenue Share by Region (2021-2032) Figure 52. Japan Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Artificial Intelligence Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032) Figure 60. SAMEA Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032) Figure 61. SAMEA Artificial Intelligence Diagnostics Revenue Share by Country (2021-2032) Figure 62. Brazil Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Artificial Intelligence Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Services
  • Software
  • Hardware
Applications
  • Radiology
  • Oncology
  • Neurology
  • Cardiology
  • Chest & Lungs
  • Others
Companies covered
  • Butterfly Network
  • Merative
  • Tempus
  • RetinAi
  • Nanox
  • Lunit
  • DiA Imaging
  • Subtle Medical
  • BrainMiner
  • GE
  • Siemens
  • Aidoc
  • Imagen Technologies, Inc.
  • VUNO, Inc.
  • Digital Diagnostics
  • NeuraSignal
  • Riverain Technologies, LLC
  • Philips
  • Microsoft
  • Viz.ai
  • RapidAI
  • Canon Medical
  • Enlitic
  • BioMind
  • ANNALISE-AI PTY LTD
  • icometrix
  • KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Intelligence Diagnostics Market by Type
  3. 1.2.1 Global Artificial Intelligence Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Services
  5. 1.2.3 Software
  6. 1.2.4 Hardware
  7. 1.3 Artificial Intelligence Diagnostics Market by Application
  8. 1.3.1 Global Artificial Intelligence Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Radiology
  10. 1.3.3 Oncology
  11. 1.3.4 Neurology
  12. 1.3.5 Cardiology
  13. 1.3.6 Chest & Lungs
  14. 1.3.7 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Artificial Intelligence Diagnostics Market Dynamics
  1. 2.1 Artificial Intelligence Diagnostics Industry Trends
  2. 2.2 Artificial Intelligence Diagnostics Industry Drivers
  3. 2.3 Artificial Intelligence Diagnostics Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artificial Intelligence Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global Artificial Intelligence Diagnostics Growth Trends by Region
  3. 3.2.1 Global Artificial Intelligence Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Intelligence Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global Artificial Intelligence Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artificial Intelligence Diagnostics Revenue by Players
  2. 4.1.1 Global Artificial Intelligence Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global Artificial Intelligence Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artificial Intelligence Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Intelligence Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artificial Intelligence Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global Artificial Intelligence Diagnostics Players, Product Type & Application
  8. 4.5 Global Artificial Intelligence Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artificial Intelligence Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 Artificial Intelligence Diagnostics Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence Diagnostics Market Size by Type
  1. 5.1 Global Artificial Intelligence Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global Artificial Intelligence Diagnostics Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence Diagnostics Market Size by Application
  1. 6.1 Global Artificial Intelligence Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artificial Intelligence Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global Artificial Intelligence Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Butterfly Network
  2. 7.1.1 Butterfly Network Company Information
  3. 7.1.2 Butterfly Network Business Overview
  4. 7.1.3 Butterfly Network Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Butterfly Network Artificial Intelligence Diagnostics Product Portfolio
  6. 7.1.5 Butterfly Network Recent Developments
  7. 7.2 Merative
  8. 7.2.1 Merative Company Information
  9. 7.2.2 Merative Business Overview
  10. 7.2.3 Merative Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merative Artificial Intelligence Diagnostics Product Portfolio
  12. 7.2.5 Merative Recent Developments
  13. 7.3 Tempus
  14. 7.3.1 Tempus Company Information
  15. 7.3.2 Tempus Business Overview
  16. 7.3.3 Tempus Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Tempus Artificial Intelligence Diagnostics Product Portfolio
  18. 7.3.5 Tempus Recent Developments
  19. 7.4 RetinAi
  20. 7.4.1 RetinAi Company Information
  21. 7.4.2 RetinAi Business Overview
  22. 7.4.3 RetinAi Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 RetinAi Artificial Intelligence Diagnostics Product Portfolio
  24. 7.4.5 RetinAi Recent Developments
  25. 7.5 Nanox
  26. 7.5.1 Nanox Company Information
  27. 7.5.2 Nanox Business Overview
  28. 7.5.3 Nanox Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Nanox Artificial Intelligence Diagnostics Product Portfolio
  30. 7.5.5 Nanox Recent Developments
  31. 7.6 Lunit
  32. 7.6.1 Lunit Company Information
  33. 7.6.2 Lunit Business Overview
  34. 7.6.3 Lunit Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Lunit Artificial Intelligence Diagnostics Product Portfolio
  36. 7.6.5 Lunit Recent Developments
  37. 7.7 DiA Imaging
  38. 7.7.1 DiA Imaging Company Information
  39. 7.7.2 DiA Imaging Business Overview
  40. 7.7.3 DiA Imaging Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 DiA Imaging Artificial Intelligence Diagnostics Product Portfolio
  42. 7.7.5 DiA Imaging Recent Developments
  43. 7.8 Subtle Medical
  44. 7.8.1 Subtle Medical Company Information
  45. 7.8.2 Subtle Medical Business Overview
  46. 7.8.3 Subtle Medical Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Subtle Medical Artificial Intelligence Diagnostics Product Portfolio
  48. 7.8.5 Subtle Medical Recent Developments
  49. 7.9 BrainMiner
  50. 7.9.1 BrainMiner Company Information
  51. 7.9.2 BrainMiner Business Overview
  52. 7.9.3 BrainMiner Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BrainMiner Artificial Intelligence Diagnostics Product Portfolio
  54. 7.9.5 BrainMiner Recent Developments
  55. 7.10 GE
  56. 7.10.1 GE Company Information
  57. 7.10.2 GE Business Overview
  58. 7.10.3 GE Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 GE Artificial Intelligence Diagnostics Product Portfolio
  60. 7.10.5 GE Recent Developments
  61. 7.11 Siemens
  62. 7.11.1 Siemens Company Information
  63. 7.11.2 Siemens Business Overview
  64. 7.11.3 Siemens Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Siemens Artificial Intelligence Diagnostics Product Portfolio
  66. 7.11.5 Siemens Recent Developments
  67. 7.12 Aidoc
  68. 7.12.1 Aidoc Company Information
  69. 7.12.2 Aidoc Business Overview
  70. 7.12.3 Aidoc Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Aidoc Artificial Intelligence Diagnostics Product Portfolio
  72. 7.12.5 Aidoc Recent Developments
  73. 7.13 Imagen Technologies, Inc.
  74. 7.13.1 Imagen Technologies, Inc. Company Information
  75. 7.13.2 Imagen Technologies, Inc. Business Overview
  76. 7.13.3 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Imagen Technologies, Inc. Artificial Intelligence Diagnostics Product Portfolio
  78. 7.13.5 Imagen Technologies, Inc. Recent Developments
  79. 7.14 VUNO, Inc.
  80. 7.14.1 VUNO, Inc. Company Information
  81. 7.14.2 VUNO, Inc. Business Overview
  82. 7.14.3 VUNO, Inc. Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  83. 7.14.4 VUNO, Inc. Artificial Intelligence Diagnostics Product Portfolio
  84. 7.14.5 VUNO, Inc. Recent Developments
  85. 7.15 Digital Diagnostics
  86. 7.15.1 Digital Diagnostics Company Information
  87. 7.15.2 Digital Diagnostics Business Overview
  88. 7.15.3 Digital Diagnostics Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Digital Diagnostics Artificial Intelligence Diagnostics Product Portfolio
  90. 7.15.5 Digital Diagnostics Recent Developments
  91. 7.16 NeuraSignal
  92. 7.16.1 NeuraSignal Company Information
  93. 7.16.2 NeuraSignal Business Overview
  94. 7.16.3 NeuraSignal Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  95. 7.16.4 NeuraSignal Artificial Intelligence Diagnostics Product Portfolio
  96. 7.16.5 NeuraSignal Recent Developments
  97. 7.17 Riverain Technologies, LLC
  98. 7.17.1 Riverain Technologies, LLC Company Information
  99. 7.17.2 Riverain Technologies, LLC Business Overview
  100. 7.17.3 Riverain Technologies, LLC Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Riverain Technologies, LLC Artificial Intelligence Diagnostics Product Portfolio
  102. 7.17.5 Riverain Technologies, LLC Recent Developments
  103. 7.18 Philips
  104. 7.18.1 Philips Company Information
  105. 7.18.2 Philips Business Overview
  106. 7.18.3 Philips Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Philips Artificial Intelligence Diagnostics Product Portfolio
  108. 7.18.5 Philips Recent Developments
  109. 7.19 Microsoft
  110. 7.19.1 Microsoft Company Information
  111. 7.19.2 Microsoft Business Overview
  112. 7.19.3 Microsoft Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Microsoft Artificial Intelligence Diagnostics Product Portfolio
  114. 7.19.5 Microsoft Recent Developments
  115. 7.20 Viz.ai
  116. 7.20.1 Viz.ai Company Information
  117. 7.20.2 Viz.ai Business Overview
  118. 7.20.3 Viz.ai Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Viz.ai Artificial Intelligence Diagnostics Product Portfolio
  120. 7.20.5 Viz.ai Recent Developments
  121. 7.21 RapidAI
  122. 7.21.1 RapidAI Company Information
  123. 7.21.2 RapidAI Business Overview
  124. 7.21.3 RapidAI Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  125. 7.21.4 RapidAI Artificial Intelligence Diagnostics Product Portfolio
  126. 7.21.5 RapidAI Recent Developments
  127. 7.22 Canon Medical
  128. 7.22.1 Canon Medical Company Information
  129. 7.22.2 Canon Medical Business Overview
  130. 7.22.3 Canon Medical Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  131. 7.22.4 Canon Medical Artificial Intelligence Diagnostics Product Portfolio
  132. 7.22.5 Canon Medical Recent Developments
  133. 7.23 Enlitic
  134. 7.23.1 Enlitic Company Information
  135. 7.23.2 Enlitic Business Overview
  136. 7.23.3 Enlitic Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  137. 7.23.4 Enlitic Artificial Intelligence Diagnostics Product Portfolio
  138. 7.23.5 Enlitic Recent Developments
  139. 7.24 BioMind
  140. 7.24.1 BioMind Company Information
  141. 7.24.2 BioMind Business Overview
  142. 7.24.3 BioMind Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  143. 7.24.4 BioMind Artificial Intelligence Diagnostics Product Portfolio
  144. 7.24.5 BioMind Recent Developments
  145. 7.25 ANNALISE-AI PTY LTD
  146. 7.25.1 ANNALISE-AI PTY LTD Company Information
  147. 7.25.2 ANNALISE-AI PTY LTD Business Overview
  148. 7.25.3 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  149. 7.25.4 ANNALISE-AI PTY LTD Artificial Intelligence Diagnostics Product Portfolio
  150. 7.25.5 ANNALISE-AI PTY LTD Recent Developments
  151. 7.26 icometrix
  152. 7.26.1 icometrix Company Information
  153. 7.26.2 icometrix Business Overview
  154. 7.26.3 icometrix Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  155. 7.26.4 icometrix Artificial Intelligence Diagnostics Product Portfolio
  156. 7.26.5 icometrix Recent Developments
  157. 7.27 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO)
  158. 7.27.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Company Information
  159. 7.27.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Business Overview
  160. 7.27.3 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Revenue and Gross Margin (2021-2026)
  161. 7.27.4 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Artificial Intelligence Diagnostics Product Portfolio
  162. 7.27.5 KONFOONG BIOTECH INTERNATIONAL CO., LTD(KFBIO) Recent Developments
8 North America
  1. 8.1 North America Artificial Intelligence Diagnostics Revenue (2021-2032)
  2. 8.2 North America Artificial Intelligence Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America Artificial Intelligence Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America Artificial Intelligence Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America Artificial Intelligence Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America Artificial Intelligence Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America Artificial Intelligence Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America Artificial Intelligence Diagnostics Revenue by Country
  11. 8.6.1 North America Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artificial Intelligence Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America Artificial Intelligence Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Artificial Intelligence Diagnostics Revenue (2021-2032)
  2. 9.2 Europe Artificial Intelligence Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artificial Intelligence Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artificial Intelligence Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artificial Intelligence Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artificial Intelligence Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artificial Intelligence Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artificial Intelligence Diagnostics Revenue by Country
  11. 9.6.1 Europe Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artificial Intelligence Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artificial Intelligence Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Artificial Intelligence Diagnostics Revenue (2021-2032)
  2. 10.2 China Artificial Intelligence Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China Artificial Intelligence Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China Artificial Intelligence Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China Artificial Intelligence Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China Artificial Intelligence Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China Artificial Intelligence Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Intelligence Diagnostics Revenue (2021-2032)
  2. 11.2 Asia Artificial Intelligence Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artificial Intelligence Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artificial Intelligence Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artificial Intelligence Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artificial Intelligence Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artificial Intelligence Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artificial Intelligence Diagnostics Revenue by Country
  11. 11.6.1 Asia Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artificial Intelligence Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artificial Intelligence Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Intelligence Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA Artificial Intelligence Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artificial Intelligence Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artificial Intelligence Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artificial Intelligence Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artificial Intelligence Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artificial Intelligence Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artificial Intelligence Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artificial Intelligence Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artificial Intelligence Diagnostics Revenue by Country
  11. 12.6.1 SAMEA Artificial Intelligence Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artificial Intelligence Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artificial Intelligence Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.